Impact of Immune Abnormalities on COVID-19 Vaccine Effectiveness
Author Information
Author(s): Muacevic Alexander, Adler John R, Chen Yunhui, Luo Wanxia, Huang Qiyu, Chen Yueming, Yao Weiping
Primary Institution: Foshan Sanshui District People's Hospital, Foshan, CHN
Hypothesis
How do immune abnormalities affect the effectiveness of COVID-19 vaccines in infected patients?
Conclusion
COVID-19 vaccination generally improves key health markers, especially in immunocompromised patients, but some vaccinated immunocompromised patients may still have elevated D-Di levels.
Supporting Evidence
- Vaccinated patients had shorter hospital stays and less severe lung involvement.
- Immunocompromised patients showed elevated LDH and CRP levels, but vaccination reduced these levels.
- Vaccination lowered the risk of coagulation-related complications in immunocompromised patients.
Takeaway
Getting vaccinated against COVID-19 helps people, especially those with weak immune systems, feel better and stay out of the hospital longer.
Methodology
This is a single-center retrospective study analyzing LDH, CRP, and D-Di levels in 338 COVID-19-infected patients based on their vaccination and immune status.
Potential Biases
Potential biases due to exclusion criteria and reliance on patient-reported vaccination status.
Limitations
The sample size may be inadequate to detect all associations, and the study is observational, limiting causal conclusions.
Participant Demographics
Mean age of participants was 62.17 years, with 69.53% having underlying medical conditions.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.270-0.810
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website